IDEAS home Printed from https://ideas.repec.org/a/wly/jocnur/v19y2010i19-20p2869-2878.html
   My bibliography  Save this article

Patients’ perceptions of information and support received from the nurse specialist during HCV treatment

Author

Listed:
  • Anne Grogan
  • Fiona Timmins

Abstract

Aim. To identify patients’ perceptions of support received from the nurse specialist during Hepatitis C virus (HCV) treatment. Background. HCV is a worldwide health problem. However, it is a treatable disease and treatment success rates are high. Unfortunately, treatment comes with a multitude of adverse side effects and patients require informational and psychological support from specialist nurses while on treatment. To date, there is little nursing research on support received from this specialist nursing care. Design. This study used a quantitative descriptive design. Method. A 59‐item questionnaire collected data from 106 patients with a diagnosis of HCV attending a HCV outpatient clinic. Results. Overall, patients were very satisfied with support received. Advice on contraception was well received. However, many patients did not feel supported with regard to advice on sleep management. There were no statistically significant differences between overall satisfaction and gender, age, genotype and risk factor. However, there were significant correlations found between support received and reported genotype. Those patients presenting with genotype 1, who are mostly infected through blood or blood products, indicated that they require more support in relation to information on side effects of treatment, quality of life and support groups. Specific approaches to support and advice for this cohort may need to be incorporated into current services. Conclusion. Results of this study reinforce the need for the ongoing use of specialist nurse services and development of this service where no such facilities exist. In addition, the service may need to further recognise and support the information and psychological needs of patients with differing modes of HCV infection. Relevance to clinical practice. Findings provide information to practising nurse specialists about patient’s views of information and support received from nurse specialists in HCV treatment centres and identify where deficits exist.

Suggested Citation

  • Anne Grogan & Fiona Timmins, 2010. "Patients’ perceptions of information and support received from the nurse specialist during HCV treatment," Journal of Clinical Nursing, John Wiley & Sons, vol. 19(19‐20), pages 2869-2878, October.
    • Handle: RePEc:wly:jocnur:v:19:y:2010:i:19-20:p:2869-2878
    DOI: 10.1111/j.1365-2702.2010.03239.x
    as

    Download full text from publisher

    File URL: https://doi.org/10.1111/j.1365-2702.2010.03239.x
    Download Restriction: no
    File URL: https://libkey.io/10.1111/j.1365-2702.2010.03239.x?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Wong, J.B. & McQuillan, G.M. & McHutchison, J.G. & Poynard, T., 2000. "Estimating future hepatitis C morbidity, mortality, and costs in the United States," American Journal of Public Health, American Public Health Association, vol. 90(10), pages 1562-1569.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Anne Grogan & Michael Coughlan & Geraldine Prizeman & Niamh O'Connell & Nora O'Mahony & Katherine Quinn & Gabrielle McKee, 2017. "The patients’ perspective of international normalized ratio self‐testing, remote communication of test results and confidence to move to self‐management," Journal of Clinical Nursing, John Wiley & Sons, vol. 26(23-24), pages 4379-4389, December.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Martin Zalesak & Kevin Francis & Alex Gedeon & John Gillis & Kyle Hvidsten & Phyllis Kidder & Hong Li & Derek Martyn & Leslie Orne & Amanda Smith & Ann Kwong, 2013. "Current and Future Disease Progression of the Chronic HCV Population in the United States," PLOS ONE, Public Library of Science, vol. 8(5), pages 1-10, May.
    2. Teresa Kauf & Ateesha Mohamed & A. Hauber & Derek Fetzer & Atiya Ahmad, 2012. "Patients’ Willingness to Accept the Risks and Benefits of New Treatments for Chronic Hepatitis C Virus Infection," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 5(4), pages 265-278, December.
    3. Craig Arthur Gallet, 2017. "The Impact of Public Health Spending on California STD Rates," International Advances in Economic Research, Springer;International Atlantic Economic Society, vol. 23(2), pages 149-159, May.
    4. Uwe Siebert, 2003. "When should decision-analytic modeling be used in the economic evaluation of health care?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 4(3), pages 143-150, September.
    5. Yanxia Wang & Qingyun Du & Fu Ren & Shi Liang & De-nan Lin & Qin Tian & Yan Chen & Jia-jia Li, 2014. "Spatio-Temporal Variation and Prediction of Ischemic Heart Disease Hospitalizations in Shenzhen, China," IJERPH, MDPI, vol. 11(5), pages 1-26, May.
    6. Susie El Saadany & Douglas Coyle & Antonio Giulivi & Mohammad Afzal, 2005. "Economic burden of hepatitis C in Canada and the potential impact of prevention," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 6(2), pages 159-165, June.
    7. Robert L. Herrick & Steven G. Buchberger & Robert M. Clark & Margaret Kupferle & Regan Murray & Paul Succop, 2012. "A Markov Model To Estimate Salmonella Morbidity, Mortality, Illness Duration, And Cost," Health Economics, John Wiley & Sons, Ltd., vol. 21(10), pages 1169-1182, October.
    8. Uwe Siebert & Gaby Sroczynski & Jürgen Wasem & Wolfgang Greiner & Ulrike Ravens-Sieberer & Pamela Aidelsburger & Bärbel Kurth & Monika Bullinger & J.-Matthias Schulenburg & John Wong & Siegbert Rossol, 2005. "Using competence network collaboration and decision-analytic modeling to assess the cost-effectiveness of interferon α-2b plus ribavirin as initial treatment of chronic hepatitis C in Germany," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 6(2), pages 112-123, June.
    9. Ebere Akobundu & Jing Ju & Lisa Blatt & C. Mullins, 2006. "Cost-of-Illness Studies," PharmacoEconomics, Springer, vol. 24(9), pages 869-890, September.
    10. Anita J Brogan & Sandra E Talbird & James R Thompson & Jeffrey D Miller & Jaime Rubin & Baris Deniz, 2014. "Cost-effectiveness of Telaprevir Combination Therapy for Chronic Hepatitis C," PLOS ONE, Public Library of Science, vol. 9(3), pages 1-11, March.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:wly:jocnur:v:19:y:2010:i:19-20:p:2869-2878. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Wiley Content Delivery (email available below). General contact details of provider: https://doi.org/10.1111/(ISSN)1365-2702 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.